PROM1 and lung carcinoma: In addition, although CD133+ CSCs are present in OSCCs, these cells are preferentially expressed in colon, brain, and lung cancer (de Moraes et al., 2017), with little information on the role of CD133+ CSCs in oral carcinogenesis.